Browse studies
Find your next paid study
339 recruiting studies matching your filters
Phase 2
A Phase 2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Sotatercept (MK-7962) in Children From 1 to Less Than 18 Years of Age With PAH on Standard of Care
The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in childre…
Pulmonary Arterial Hypertension
Estimated
~$10 – $8,750
Merck Sharp & Dohme LLCNCT05587712
Observational
Evaluation of the Performance of the VenusP-ValveTM System in Patients with Native RVOT Dysfunction
A prospective, multi-center, non-randomized interventional study to evaluate the safety and effectiveness of the VenusP-ValveTM System in patients with native …
Pulmonary Regurgitation
Estimated
~$10 – $8,750
Venus MedTech (HangZhou) Inc.NCT06010563
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals
Pulmonary arterial hypertension (PAH) is a severe disease with a delayed diagnosis and markedly elevated mortality. High-risk populations, such as those with k…
Idiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionUnaffected Mutation Carriers: Healthy Participants With a Known BMPR2 Gene Mutation and Normal Pulmonary Pressure and RV Function on Echo+1 more
Estimated
~$10 – $750
Vanderbilt University Medical CenterNCT05584722